ANLOTINIB

Clinical trials for ANLOTINIB explained in plain language.

Never miss a new study

Get alerted when new ANLOTINIB trials appear

Sign up with your email to follow new studies for ANLOTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New triple combo aims to tackle Hard-to-Treat liver cancer

Disease control Not yet recruiting

This phase 2 trial tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few other spots and no longer responds to first-line treatment. The goal is to see if this triple therapy can slow …

Matched conditions: ANLOTINIB

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

ANLOTINIB

Get alerted when new ANLOTINIB trials appear

New triple combo aims to tackle Hard-to-Treat liver cancer